Silicon Laboratories Inc has a consensus price target of $153.75 based on the ratings of 16 analysts. The high is $208 issued by Morgan Stanley on December 15, 2021. The low is $86 issued by Morgan Stanley on November 2, 2023. The 3 most-recent analyst ratings were released by Needham, Citigroup, and Barclays on July 25, 2024, April 25, 2024, and April 25, 2024, respectively. With an average price target of $130 between Needham, Citigroup, and Barclays, there's an implied 8.05% upside for Silicon Laboratories Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/25/2024 | Buy Now | 24.67% | Needham | Quinn Bolton | $150 → $150 | Reiterates | Buy → Buy | Get Alert |
04/25/2024 | Buy Now | -0.27% | Citigroup | Atif Malik | $137 → $120 | Maintains | Neutral | Get Alert |
04/25/2024 | Buy Now | -0.27% | Barclays | Blayne Curtis | $140 → $120 | Maintains | Equal-Weight | Get Alert |
04/25/2024 | Buy Now | 24.67% | JP Morgan | Peter Peng | $165 → $150 | Maintains | Overweight | Get Alert |
04/25/2024 | Buy Now | — | Benchmark | Cody Acree | — | Reiterates | → Hold | Get Alert |
04/25/2024 | Buy Now | 24.67% | Needham | Quinn Bolton | → $150 | Upgrade | Hold → Buy | Get Alert |
02/08/2024 | Buy Now | 16.36% | Barclays | Blayne Curtis | $120 → $140 | Maintains | Equal-Weight | Get Alert |
02/08/2024 | Buy Now | 37.13% | JP Morgan | Peter Peng | $145 → $165 | Maintains | Overweight | Get Alert |
01/16/2024 | Buy Now | -0.27% | Barclays | Blayne Curtis | $80 → $120 | Maintains | Equal-Weight | Get Alert |
01/02/2024 | Buy Now | 28.82% | Stifel | Tore Svanberg | $136 → $155 | Maintains | Buy | Get Alert |
12/08/2023 | Buy Now | 20.51% | JP Morgan | Peter Peng | → $145 | Initiates | → Overweight | Get Alert |
11/02/2023 | Buy Now | -28.52% | Morgan Stanley | Craig Hettenbach | $110 → $86 | Maintains | Equal-Weight | Get Alert |
11/02/2023 | Buy Now | 8.05% | Keybanc | John Vinh | $180 → $130 | Maintains | Overweight | Get Alert |
11/02/2023 | Buy Now | — | Barclays | Blayne Curtis | — | Upgrade | Underweight → Equal-Weight | Get Alert |
10/30/2023 | Buy Now | -8.58% | Morgan Stanley | Craig Hettenbach | $154 → $110 | Maintains | Equal-Weight | Get Alert |
10/19/2023 | Buy Now | 41.29% | Stifel | Tore Svanberg | $186 → $170 | Maintains | Buy | Get Alert |
07/31/2023 | Buy Now | 23.01% | Citigroup | Atif Malik | $165 → $148 | Maintains | Neutral | Get Alert |
07/27/2023 | Buy Now | 27.99% | Morgan Stanley | Craig Hettenbach | $159 → $154 | Maintains | Equal-Weight | Get Alert |
07/27/2023 | Buy Now | 49.6% | Keybanc | John Vinh | $200 → $180 | Maintains | Overweight | Get Alert |
07/07/2023 | Buy Now | — | Raymond James | Srini Pajjuri | — | Initiates | → Market Perform | Get Alert |
05/31/2023 | Buy Now | 37.13% | Citigroup | Atif Malik | $186 → $165 | Maintains | Neutral | Get Alert |
04/27/2023 | Buy Now | 32.15% | Morgan Stanley | Craig Hettenbach | $207 → $159 | Maintains | Equal-Weight | Get Alert |
04/27/2023 | Buy Now | 49.6% | TD Cowen | Matthew Ramsay | $200 → $180 | Maintains | Outperform | Get Alert |
04/27/2023 | Buy Now | 66.22% | Keybanc | John Vinh | $210 → $200 | Maintains | Overweight | Get Alert |
02/07/2023 | Buy Now | 54.59% | Citigroup | Atif Malik | $150 → $186 | Maintains | Neutral | Get Alert |
02/02/2023 | Buy Now | 57.91% | Wells Fargo | Gary Mobley | $155 → $190 | Maintains | Overweight | Get Alert |
02/02/2023 | Buy Now | 66.22% | Cowen & Co. | Matthew Ramsay | $175 → $200 | Maintains | Outperform | Get Alert |
02/02/2023 | Buy Now | 72.04% | Morgan Stanley | Craig Hettenbach | $151 → $207 | Maintains | Equal-Weight | Get Alert |
02/02/2023 | Buy Now | — | Summit Insights Group | Kinngai Chan | — | Upgrade | Hold → Buy | Get Alert |
02/02/2023 | Buy Now | 74.53% | Keybanc | John Vinh | $160 → $210 | Maintains | Overweight | Get Alert |
01/23/2023 | Buy Now | -16.89% | Barclays | Blayne Curtis | $85 → $100 | Maintains | Underweight | Get Alert |
01/09/2023 | Buy Now | 28.82% | Wells Fargo | Gary Mobley | $145 → $155 | Maintains | Overweight | Get Alert |
10/27/2022 | Buy Now | -29.36% | Barclays | Blayne Curtis | $95 → $85 | Maintains | Underweight | Get Alert |
10/27/2022 | Buy Now | 25.5% | Morgan Stanley | Craig Hettenbach | $161 → $151 | Maintains | Equal-Weight | Get Alert |
10/27/2022 | Buy Now | — | Needham | Rajvindra Gill | — | Downgrade | Buy → Hold | Get Alert |
10/27/2022 | Buy Now | 32.98% | Keybanc | John Vinh | $180 → $160 | Maintains | Overweight | Get Alert |
10/24/2022 | Buy Now | -21.04% | Barclays | Blayne Curtis | $140 → $95 | Downgrade | Equal-Weight → Underweight | Get Alert |
07/28/2022 | Buy Now | 33.81% | Morgan Stanley | Craig Hettenbach | $156 → $161 | Maintains | Equal-Weight | Get Alert |
07/28/2022 | Buy Now | — | Summit Insights Group | Kinngai Chan | — | Downgrade | Buy → Hold | Get Alert |
07/28/2022 | Buy Now | 37.13% | Needham | Rajvindra Gill | $150 → $165 | Maintains | Buy | Get Alert |
07/11/2022 | Buy Now | 41.29% | Wells Fargo | Gary Mobley | $190 → $170 | Maintains | Overweight | Get Alert |
04/28/2022 | Buy Now | 99.47% | Needham | Rajvindra Gill | $230 → $240 | Maintains | Buy | Get Alert |
04/28/2022 | Buy Now | 49.6% | Keybanc | John Vinh | $210 → $180 | Maintains | Overweight | Get Alert |
04/25/2022 | Buy Now | 29.65% | Morgan Stanley | Joseph Moore | $208 → $156 | Maintains | Equal-Weight | Get Alert |
03/07/2022 | Buy Now | 91.16% | Needham | Rajvindra Gill | $210 → $230 | Maintains | Buy | Get Alert |
12/21/2021 | Buy Now | 87% | Wells Fargo | Gary Mobley | $190 → $225 | Maintains | Overweight | Get Alert |
12/15/2021 | Buy Now | 72.87% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
11/12/2021 | Buy Now | 87% | Stifel | Tore Svanberg | — | Maintains | Buy | Get Alert |
10/28/2021 | Buy Now | 59.57% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
10/28/2021 | Buy Now | 32.98% | Barclays | Blayne Curtis | — | Maintains | Equal-Weight | Get Alert |
10/28/2021 | Buy Now | 74.53% | Needham | Rajvindra Gill | — | Maintains | Buy | Get Alert |
10/28/2021 | Buy Now | 74.53% | Keybanc | John Vinh | — | Maintains | Overweight | Get Alert |
07/29/2021 | Buy Now | 27.16% | Morgan Stanley | Craig Hettenbach | — | Maintains | Equal-Weight | Get Alert |
The latest price target for Silicon Laboratories (NASDAQ:SLAB) was reported by Needham on July 25, 2024. The analyst firm set a price target for $150.00 expecting SLAB to rise to within 12 months (a possible 24.67% upside). 17 analyst firms have reported ratings in the last year.
The latest analyst rating for Silicon Laboratories (NASDAQ:SLAB) was provided by Needham, and Silicon Laboratories reiterated their buy rating.
The last upgrade for Silicon Laboratories Inc happened on April 25, 2024 when Needham raised their price target to $150. Needham previously had a hold for Silicon Laboratories Inc.
The last downgrade for Silicon Laboratories Inc happened on October 27, 2022 when Needham changed their price target from N/A to N/A for Silicon Laboratories Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Silicon Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Silicon Laboratories was filed on July 25, 2024 so you should expect the next rating to be made available sometime around July 25, 2025.
While ratings are subjective and will change, the latest Silicon Laboratories (SLAB) rating was a reiterated with a price target of $150.00 to $150.00. The current price Silicon Laboratories (SLAB) is trading at is $120.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.